WOMEN'S CAPITAL LCC – Trademark Portfolio

Entity Type: 16

WOMEN'S CAPITAL LCC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include PLAN B and PLAN B ONE-STEP. The owner is based in PARSIPPANY, NJ.

400 INTERPACE PARKWAY

BUILDING A

PARSIPPANY, NJ 07054

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

WOMEN'S CAPITAL LCC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does WOMEN'S CAPITAL LCC have?

WOMEN'S CAPITAL LCC has 7 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 abandoned.

What trademark classes does WOMEN'S CAPITAL LCC file in?

WOMEN'S CAPITAL LCC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are WOMEN'S CAPITAL LCC's most well-known trademarks?

WOMEN'S CAPITAL LCC's registered trademark portfolio includes well-known marks such as PLAN B and PLAN B ONE-STEP. These are among 6 currently registered trademarks in the portfolio.

What is WOMEN'S CAPITAL LCC's trademark registration success rate?

WOMEN'S CAPITAL LCC has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.